Clinical trial · Observational
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. A Cross-sectional Study Focusing on Older Survivors. Part I and IIA
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, addressing prostate cancer survivors, i.e. men who received potentially curative (radical) treatment two to six years ago, we will investigate if older age at time of treatment is a detrimental factor with respect to long-term quality of life (Qol), health, and function. We will also compare QoL, health and function between the prostate cancer survivors and matched population based cohorts, and thereby provide realistic information on the long-term impact of radical prostate cancer treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Study group
- description
- Men who have been treated for localized or locally advanced prostate cancer with curative intent
- label
- Matched population based controls
- description
- Existing population based data from men who participated in the Trøndelag Health Survey 2017-2019
Primary outcomes (2)
- measure
- Global quality of life
- timeFrame
- at time of assessment (cross-sectional)
- description
- Global quality of life assessed by the EORTC QLQ-C30 questionnaire's global QoL scale ranging from 0 to 100, higher scores indicate better QoL
- measure
- General health
- timeFrame
- at time of assessment (cross-sectional)
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria. Study group: Study I: a) men who received radical radiotherapy or robot-assisted radical prostatectomy for prostate cancer at Innlandet Hospital Trust 01.01.2014 and 31.12.2018; b) alive and living in Innlandet County; c) fluent in Norwegian (orally and in writing); provide written informed consent Study IIa) the subgroup of participants in Study I who were \> 70 years by the time of treatment. Exclusion Criteria: None \-
References
Publications (0)
Data not yet available